Giuseppe Giaccone
0000-0002-5023-7562
Publication & Citation Trends
Publications
1,115 total
Reproducibility of the WHO classification of thymomas: practical implications. OA
Cited by 42
Semantic Scholar
Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line chemotherapy. OA
Cited by 103
Semantic Scholar
A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion.
Cited by 22
Semantic Scholar
Role of cMET expression in non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors. OA
Cited by 96
Semantic Scholar
The determination of gemcitabine and 2'-deoxycytidine in human plasma and tissue by APCI tandem mass spectrometry.
Cited by 47
Semantic Scholar
Subcellular localization and nucleocytoplasmic transport of the chromosomal passenger proteins before nuclear envelope breakdown OA
Cited by 47
Semantic Scholar
Phase I evaluation of AZD2171, a highly potent, selective VEGFR signaling inhibitor, in combination with gefitinib, in patients with advanced tumors.
Cited by 16
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(364)
Lung Cancer Research Studies
(205)
Myasthenia Gravis and Thymoma
(130)
Cancer therapeutics and mechanisms
(114)
Colorectal Cancer Treatments and Studies
(107)
Affiliations
BGI Group (China)
AstraZeneca (United Kingdom)
University of Pisa
Ontario Institute for Cancer Research
Roche (Switzerland)